Abbott Laboratories Newsroom

Abbott Laboratories Analyst Ratings

BenzingaJul 2 22:57

Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $125, Maintains Outperform Rating

MT NewswiresJul 2 19:45

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Springworks Therapeutics (SWTX)

TipRanksJul 2 19:04

Barclays Keeps Their Buy Rating on Abbott Laboratories (ABT)

TipRanksJul 2 19:03

Abbott Laboratories Analyst Ratings

BenzingaJun 4 21:40

RBC Capital Reiterates Outperform on Abbott Laboratories, Maintains $125 Price Target

BenzingaJun 4 21:40

Abbott: Goldman Sachs starts reporting with a buy rating; target share price is $121

Zhitong FinanceMay 31 17:18

Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115

MT NewswiresMay 30 21:17

Abbott Laboratories (ABT.US) was first covered by Goldman Sachs and given a buy rating, with a target price of $121.00.

Zhitong FinanceMay 30 19:40

Abbott Laboratories Analyst Ratings

BenzingaMay 30 19:40

Goldman Sachs Initiates Coverage On Abbott Laboratories With Buy Rating, Announces Price Target of $121

BenzingaMay 30 19:40

Optimistic Buy Rating for Abbott Laboratories on Diverse Portfolio and Growth Prospects

TipRanksMay 30 16:27

Critical Insights From Abbott Laboratories Analyst Ratings: What You Need To Know

BenzingaMay 23 02:05

Abbott Laboratories Analyst Ratings

BenzingaMay 23 01:20

Citi: Maintains the Abbott Laboratories (ABT.US) rating, adjusted from buy to buy rating, and adjusted the target price from $128.00 to $119.00.

Zhitong FinanceMay 23 01:20

Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating

MT NewswiresMay 22 17:57

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Immunocore Holdings (IMCR) and Madrigal Pharmaceuticals (MDGL)

TipRanksMay 20 19:31

Analysts Conflicted on These Healthcare Names: Abbott Laboratories (ABT), PolyPid (PYPD) and GoodRx Holdings (GDRX)

TipRanksMay 20 18:01

Buy Rating Affirmed for Abbott Laboratories Based on Strong EP Business and Strategic Growth Prospects

TipRanksMay 20 16:20

RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT)

TipRanksMay 7 20:11